Abstract |
Although there is presently no definitive evidence linking vaccinia virus transmission through reproductive cells, SART/ASRM accordingly recommends that ART practitioners consider deferring donors who have recently received smallpox vaccine or contracted symptomatic vaccinia virus infection through close contact with a vaccine recipient (until after the vaccine or infectious scab has spontaneously separated). Good donor practice further suggests that donors who are not in good health, including those with recent complications from smallpox vaccine, should be similarly deferred. (This document was reviewed by the ASRM Practice Committee in 2011).
|
Authors | Practice Committees of American Society for Reproductive Medicine and Society for Reproductive Technology |
Journal | Fertility and sterility
(Fertil Steril)
Vol. 98
Issue 1
Pg. e1-2
(Jul 2012)
ISSN: 1556-5653 [Electronic] United States |
PMID | 22537381
(Publication Type: Journal Article, Practice Guideline)
|
Copyright | Copyright © 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved. |
Chemical References |
|
Topics |
- Advisory Committees
- Donor Selection
(legislation & jurisprudence)
- Expert Testimony
- Female
- Humans
- Male
- Practice Guidelines as Topic
- Reproductive Techniques, Assisted
(legislation & jurisprudence, standards)
- Smallpox Vaccine
(isolation & purification, metabolism)
- Tissue Donors
(legislation & jurisprudence)
- Vaccinia
(prevention & control, transmission)
- Vaccinia virus
(isolation & purification, physiology)
|